发明名称 |
Ultra low dose oral contraceptives with sustained efficacy that induces amenorrhea |
摘要 |
<p>A method of female contraception involves administering a combination of estrogen and progestin continuously for more than a year in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include lack of menstrual bleeding, less patient anemia, less total exposure to medication when compared to a 35 microgram (low dose) containing oral contraceptive, reduced risk of endometrial cancer, higher compliance rates and more lifestyle convenience for patients who desire less uterine bleeding each year or longer.</p> |
申请公布号 |
EP1275394(A3) |
申请公布日期 |
2003.01.29 |
申请号 |
EP20020254789 |
申请日期 |
2002.07.09 |
申请人 |
MEDICAL COLLEGE OF HAMPTON ROADS |
发明人 |
HODGEN, GARY D.;ANDERSON, FREEDOLPH D.;WILLIAMS, ROBERT F. |
分类号 |
A61K31/567;A61K31/565;A61P15/18;(IPC1-7):A61K31/565;A61K31/569 |
主分类号 |
A61K31/567 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|